The coefficient of variation for orforglipron plasma exposure (AUC and Cmax) across Phase 1 studies was moderate and consistent with typical oral small-molecule drugs, whereas oral semaglutide shows substantially higher variability due to the sensitivity of SNAC-mediated gastric absorption to physiological factors including gastric pH, motility, and volume
The SELECT trial, published in 2024, showed that semaglutide reduced major adverse cardiovascular events (MACE: heart attack, stroke, cardiovascular death) by 20% in individuals with obesity, even independent of weight loss magnitude. Why
Conventional cancer therapy typically eradicates the majority of cancerous cells while concurrently triggering senescence in the remaining few cells (first punch)
Electrolyte imbalances from rapid weight loss can cause physical symptoms that trigger panic
You can use B12 injections as a supplement if you feel you are not getting enough vitamin B12 through your food
These were early-stage studies of BPC-157 as a cytoprotective agent for ulcerative colitis, and they were never completed to approval